Related Experiment Videos
Molecular prognostic factors in bladder cancer
Maurizio Buscarini1, Marcus L Quek, Parkash Gill
1Department of Urology, Kenneth Norris Jr. Comprehensive Cancer Center, University of Southern Californua Keck School of Medicine, Los Angeles, California 90089, USA.
BJU International
|March 30, 2005
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Outcomes for females versus males treated with eribulin mesylate for advanced urothelial carcinoma.
Current problems in cancer·2026
Efficacy and Genomic Analysis of HER2-Mutant Metastatic Triple-Negative Breast Cancer Treated with Neratinib Alone or with Trastuzumab in the SUMMIT Basket Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Clinical characteristics and prognostic factors associated with recurrence in periocular basal cell carcinoma in a Taiwanese population.
Japanese journal of ophthalmology·2026
Is early combination therapy associated with lower risk of respiratory failure in severely immunocompromised hosts with COVID-19? a target trial emulation study from the omicron-dominant era.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
DBF4B promotes hepatocellular carcinoma progression by regulating CCNA2 and PSMD11 expression.
Molecular biology reports·2026